The promise of medical research and public health to enhance and extend lives has never been greater. Regrettably, the obstacles to funding and delivering innovation remain substantial. This panel will explore the full range of health interventions--from prevention and researching improved treatments to care--and how we fund them.

What measures are most effective in motivating people to make better health decisions?
How are biopharma companies and disease-specific organizations working with governments, medical research institutions, and foundations to accelerate progress?
How can we improve the delivery and reduce the cost of care?

Welcome Remarks
Ed Greissing, Executive Director, Center for Public Health, Milken Institute

Moderator
Katie Couric, Global News Anchor, Yahoo

Speakers
Mark Alles, CEO, Celgene Corporation
Tom Beauregard, Chief Innovation Officer, UnitedHealth Group
Linda Fried, Dean and DeLamar Professor of Public Health, Mailman School of Public Health, Columbia University; Senior Vice President, Columbia University Medical Center
Eric Lefkofsky, Co-Founder and CEO, Tempus
Jim Robinson, President, Astellas Americas